Skip to main content
NewslettersWatchlist

Pieris Pharmaceuticals Inc(PIRS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Pieris Pharmaceuticals Inc

225 Franklin Street 26th Floor
Boston MA 02110 USA
P: 857-246-8998
http://www.pieris.com

Sectors & Indices

Sector
Industry
Employees

Profile

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

Key Executives

NameTitle
Stephen S. YoderCEO/Director/President
Thomas BuresCFO/Chief Accounting Officer/Senior VP

More from The Globe

investor newsletter
A change in market leadership may be imminent. Plus, an index-beating U.S. dividend portfolio strategy
Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1, 2024. (AP Photo/Seth Wenig)
Tensions rise in Silicon Valley over sales of startup stocks
SpaceX logo and Elon Musk silhouette are seen in this illustration taken, December 19, 2022.
How pro money managers are balancing exposure to Canadian and U.S. stocks
Rob Carrick
At the open: North American stock markets rise as rate-cut hopes linger
Traders work on the floor of the New York Stock Exchange (NYSE) on May 3.
The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada
A trader works inside a booth on the floor of the New York Stock Exchange on May 1.
The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings
Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1.
Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks
Former President Donald Trump speaks to reporters as he leaves the courtroom for the day at Manhattan criminal court, in New York, U.S., April 30, 2024. Seth Wenig/Pool via REUTERS
The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive
NEW YORK, NEW YORK - APRIL 29: Traders work on the floor of the New York Stock Exchange during morning trading on April 29, 2024 in New York City. Stocks opened high Monday morning amid a Federal Reserve rate decision and the monthly jobs report later this week. (Photo by Michael M. Santiago/Getty Images)

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.